Advertisement


Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Deborah Collyar: What's In It for Patients?

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement



Dec
02
Today In Oncology
Lung Cancer Screening May Increase Long-Term Survival Rate
High Deductibles May Discourage Patients From Receiving Additional Testing After an Abnormal Mammogram
Study Finds Americans Have a Low Awareness of the Link Between Alcohol Use and Increased Cancer Risk
Does CBD Oil Improve Symptom Distress in Patients With Advanced Cancer Receiving Palliative Care
Incidence of Cervical Cancer in Women in the United States 2001 to 2019
View More 
Advertisement
© 2022 HSP News Service, L.L.C.
Designed by Harborside